http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2624903-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f13cae8f02a25d08464a6ace7c946c7e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c244f6c9c3f82c98a141a270a8fe7633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24899fcf2fd5b966d14a468a7760a39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_851dc55f01f36de0a1e8783b985c5172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac917a5bc3ada49e73b5483ec16659d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a3caee765f0d79edeb3d97a62092bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_783862d791624a7215d9324eed2e1e2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd3770f44a27f0a783789d586cc6424
publicationDate 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2624903-C1
titleOfInvention Vanilin derivatives with antitumour activity
abstract FIELD: pharmacology. n SUBSTANCE: invention relates to the new antitumour agents based on vanillin derivatives of the general formula I n I, n where R=H, CH 3 with high antitumour activity against breast cancer cells (MCF-7) and low toxicity. n EFFECT: increased activity of agents. n 1 tbl, 3 ex
priorityDate 2016-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009064449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2450009-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8419
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451431471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1183
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532281
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429559399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132938017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527323
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86591708
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034

Total number of triples: 52.